A Phase 1 Open‐Label, Randomized, Parallel‐Group Study in Healthy Subjects to Investigate the Effect of Different Storage Conditions of a Long‐Acting Nanosuspension of Rilpivirine on the Single‐Dose Plasma Pharmacokinetics of Rilpivirine After Intramuscular Injection
Phase of Trial: Phase I
Latest Information Update: 13 Jul 2016
At a glance
- Drugs Rilpivirine (Primary) ; Rilpivirine
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Janssen Infectious Diseases BVBA
- 14 Jun 2016 Status changed from recruiting to completed.
- 30 Sep 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 17 Sep 2015 New trial record